represented. Comparisons between the different studies are difficult since useful seizure outcome scales, such as Engel's classification or the International League Against Epilepsy (ILAE) classification, are usually not reported. Overall, there is a shortage of detailed and useful data regarding pediatric patients with different types of epilepsy and long-term epileptological follow-up after surgery. 1 The purpose of this paper is to generate data for a thorough counseling of patients and caregivers.
Methods

Inclusion and Exclusion Criteria
The neurosurgical index database and the epilepsy surgery database were screened for procedures performed between 1988 and 2010. A total of 168 patients with CCM-associated epilepsy were identified. Among these, 22 patients were younger than 19 years (13%). Fifty-one pediatric patients with CCMs of all CNS localizations underwent surgery at our institution in this period. Twenty-nine patients harboring CCMs in nonepileptogenic areas, for example, basal ganglia, thalamus, cerebellum, brainstem, or spinal CCMs, were excluded, except for patients with multiple CCMs. Six patients with multiple CCMs and epilepsy in whom all epileptogenic CCMs were located cortically or subcortically were included. We included only cases with histopathological confirmation of CCM. All biopsy specimens underwent neuropathological analysis, and only cases with concordant neuropathological, neuroradiological, and intraoperative findings, particularly unequivocal exclusion of arteriovenous malformations, were considered for this study. Analyzed data included patient age, sex, age at seizure onset and type of seizures, duration of symptoms, surgical approach, extent of resection, and surgical morbidity and mortality, as well as seizure outcome according to ILAE classification. Only patients with follow-up longer than 12 months were included in the study.
Categorization of Localization
Localization of the CCMs was analyzed on the basis of radiological images, radiological reports, and surgical records. Localization of symptomatic CCMs was divided into different categories. Temporal localization was subdivided into temporolateral neocortical and temporomesial archicortical localization. Furthermore, symptomatic CCMs were considered to be in an eloquent location if the symptomatic CCM was located in the precentral or postcentral gyrus or in Wernicke's (angularis region) or Broca's area of the presumed dominant hemisphere, as well as in the primary visual cortex. All other CCMs were considered as being localized in noneloquent brain regions.
Categorization of Duration of Epilepsy
Patients were assigned to the shorter symptom duration group (Group A) if they had symptoms for less than 2 years. If seizure duration was longer than 2 years, patients were categorized in Group B.
Presurgical Epileptological Workup
Patients with drug-resistant epilepsy underwent detailed epileptogical evaluation assessing medical history with special focus on seizure semiology. Thorough epileptological workup also included high-quality MRI. 25 Long-term video-electroencephalography (EEG) monitoring and in some cases invasive monitoring with strip or grid electrodes was performed. Standards and techniques of presurgical evaluation have been published. 5 
Surgical Technique and Extent of Resection
Extent of resection was evaluated by analysis of surgical records and, if available, postoperative MRI findings. Resection types were classified into lesionectomy (the hemosiderotic rim was completely or partially removed) and extended lesionectomy. Extended lesionectomy was usually performed as tailored resection (lesionectomy including rim and adjacent neocortex). In selected cases, lesionectomy including temporomesial resection (cases in which the lesion and the hemosiderotic rim as well as amygdala and hippocampus/parahippocampal gyrus were removed) was performed.
Follow-Up and Seizure Outcome
Follow-up data were obtained by regular outpatient visits, routinely performed at 3, 6, and 12 months postoperatively. Also, all patients and/or caregivers and/or their general practitioners/neurologists were contacted by phone with standardized interviews and were asked to provide information on further seizure history and antiepileptic medication, subsequent neurosurgical or neurological hospital admissions, or any other subsequent neurosurgical procedure. Seizure outcome was determined using ILAE classification.
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Statistical Analysis
To analyze descriptive population statistics and potential associations of factors with postoperative seizure outcome we used SPSS (version 20, IBM). Statistical significance was reached at p < 0.05.
Results
Patient and Demographic Data
We identified 22 patients younger than 19 years; 14 (64%) of these patients were male. The mean age at onset of seizure activity was 11.3 ± 4.6 years ([± SD] range 2-18 years), and the mean age at surgery was 13.9 ± 4.3 years (range 3-18 years). The mean duration of seizures was 30.4 ± 39.2 months (range 0.03-144 months). In 4 patients seizures occurred as a symptom of recent significant intracerebral hemorrhage from CCM (see Tables 2 and 3 for details).
Localization of Symptomatic CCMs
Sixteen patients had single supratentorial CCMs. Nine (56.2%) of these 16 CCMs were located in the left hemisphere. In 19% the symptomatic CCM was located in eloquent brain regions; 6 CCMs (38%) were temporal ( Fig. 1) . Temporal localization was statistically not predisposing for longstanding symptom duration (p > 0.05).
Six patients with multiple CCMs harbored 27 CCMs overall (mean 4.5, range 3-6) ( Fig. 1 ). In these 6 patients, a total of 8 symptomatic CCMs were removed. Regarding the localization of the removed lesions, 37.5% of these were located in the temporal lobe and 37.5% in eloquent brain regions.
Clinical Data and Duration of Symptoms
The patients were divided into 2 groups according to their preoperative duration of seizures, which they experienced presurgically. Eleven patients had symptoms for less than 2 years (Group A). The remaining 11 patients had symptoms for more than 2 years (Group B). Among the 11 patients in Group B, 8 patients were diagnosed as having drug-resistant epilepsy.
The mean age at seizure onset in Group A was 12 years, and the mean age at surgery was 12.5 years. The mean duration of seizures in Group B was 57.8 months.
The mean age at seizure onset was 10.6 years, and the mean age at surgery was 15.3 years in Group B (see also Table 2 for other details of the groups).
Preoperative Workup
Detailed epileptological evaluation was done in 9 (41%) of 22 patients. Detailed workup was done in 8 patients in Group B (72.7%) and in 1 patient in Group A (9%). In 7 (87.5%) of the 8 patients in Group B, electrophysiological diagnostics showed concordance between localization of the CCM and ictal focus; the remaining patient underwent invasive diagnostic testing (see below).
Detailed epileptological workup was done in 4 (67%) of 6 patients with multiple CCMs to identify the symptomatic CCM. Electrophysiological data were conclusive in 3 of those patients (75%); the remaining patient underwent invasive monitoring.
Invasive Monitoring
Overall, invasive EEG recording was performed in 2 patients. Findings from noninvasive epileptological workup were inconclusive in these patients, and therefore they underwent subdural grid electrode and depth electrode implantation. One patient in Group B (Case 4, Table  3 ) had drug-resistant epilepsy potentially due to a temporomesial CCM located in the parahippocampal gyrus. Noninvasive surface EEG was not sufficient to determine if the epileptogenic area included the temporomesial structures. This patient underwent stereotactic implantation of bilateral hippocampal depth electrodes and 2 leftsided subtemporal 4-contact strip electrodes.
The other patient (Case 13, Table 3 ), who was in Group A, harbored 3 superficial multiple CCMs in the left parasagittal frontal cortex, in the left occipitobasal cortex, and in the left frontolateral region. Surface EEG recorded 2 seizures for which no focus could be delineat- ed. Ictal SPECT evaluation was also not conclusive. This patient was implanted with a total of 8 strip electrodes covering all CCMs. Neither of these patients developed a postoperative complication due to the implantation procedure, and both were seizure free at last available outcome.
Surgical Management
In Group B, 9 (81.8%) of 11 patients underwent extended lesionectomy. In these cases the lesion itself and the hemosiderotic rim as well as the adjacent cortex were removed. Two patients in Group B (18.2%) underwent lesionectomy. In 1 patient (12.5%), multiple subpial transections were added to the extended resection. In this patient (Case 2), the epileptological workup revealed an overlapping of the epileptogenic zone and the Wernicke area (Table 3 ). In Group A the surgical strategy was different. Nine patients (81.8%) underwent lesionectomy including complete or partial removal of the hemosiderotic rim (Fig. 2) . In summary, the longer the clinical symptoms of epilepsy, the more extensive the resection (p = 0.008; Fig. 2 ).
Surgical Morbidity and Mortality
In 8 of 11 patients in Group B, the postoperative course was uneventful. One patient developed quadrantanopia, as anticipated (a calculated deficit that was discussed and accepted prior to surgery). One patient developed transient mild anomia and mild amnesic aphasia. The patient recovered well with speech therapy and was not impaired at the last available follow-up. Another patient developed a permanent sensory deficit (calculated deficit) due to removal of a symptomatic postcentral CCM. In Group A, 1 patient developed a permanent unanticipated mild motor aphasia due to pure lesionectomy of a symptomatic CCM in the proximity of Broca's area. The overall rate of mild permanent, unanticipated postoperative deficits was 4.5%. The rate of anticipated deficits was 9%. There were no systemic or local complications in the entire study group. 
Seizure Outcome
The mean follow-up in Group A was 125.3 months (median 103 months, range 20-202 months), and the mean follow-up in Group B was 132.5 months (median 163 months, range 23-260 months). Seizure outcome was excellent in Group A since ILAE Class 1 was achieved in all patients. Seizure outcome was significantly worse in Group B (chi-square test, p = 0.02). Seven patients were seizure free after surgery (63.6%), and 4 patients did not become seizure free. At the stage of last available followup, ILAE Class 2 was achieved in 2 patients in Group B, ILAE Class 3 in 1 patient, and ILAE Class 4 in 1 patient (Table 4) .
Outcome was stable over the years. Ten patients in Group A were available for analysis of seizure freedom 5 years after surgery. All of these patients were seizure free. Seven patients in Group B had a follow-up period of longer than 5 years, 5 of whom were seizure free (71.4%).
Overall, seizure outcome is not significantly correlated with the number of CCMs (single vs multiple). Regarding the entire study population, presurgical duration of seizure symptoms is correlated with worse seizure outcome (Mann-Whitney U-test, p = 0.01). Regarding antiepileptic drug (AED) weaning, 5 (26.3%) of 19 patients with ILAE Class 1 and 2 outcomes are still on AED treatment; 59.1% of all patients with CCM-associated epilepsy are no longer being treated with AEDs.
Discussion
The present study analyzed one of the largest singlecenter cohorts of pediatric patients with CCM-associated seizures and epilepsy. 1, 13, 17 One of the most common symptoms of CCMs are seizures, and there is still uncertainty regarding if and when to treat patients surgically. Should a CCM that is easy to reach surgically and is symptomatic with a single seizure be treated with AEDs? Is it harmful to wait for refractory epilepsy to start thinking of surgery?
Counseling patients and caregivers of sick children can be a very challenging, and extensive data are needed. This is of particular importance in planning elective procedures, such as the resection of a CCM.
A detailed and interdisciplinary approach is known to maximize potential postoperative seizure outcome. 4 Patients with longstanding epilepsy in particular may benefit from detailed epileptological evaluation, since in those cases it is known that remote epileptogenic foci can develop. 15, 28 It has been shown in adult patients that virtually all patients who experience a first seizure associated with a CCM will develop epilepsy in a 5-year follow-up period.
14 Multimodal workup diagnostic testing enables the surgeon to individually tailor the extent of resection. Until now, it has not been shown that a thorough epileptological workup influences the seizure outcome in pediatric patients with CCM-associated epilepsy. In the present series, detailed epileptological workup was done in 9 (41%) of the 22 patients, all of whom presented with either a longstanding form of epilepsy or multiple CCMs. The presurgical workup resulted in an extended lesionectomy in 82% of patients. Of these cases, ILAE Class 1 was achieved in 75%. Since there were only 2 patients with longstanding forms of epilepsy who did not undergo epileptological workup, performing a comparison between those patients who were evaluated and those who were not did not make sense. Nonetheless, the presented seizure outcomes, especially in patients with longer symptom duration and in patients with epilepsy associated with multiple CCMs, are in line with the published data and support a combined interdisciplinary approach to maximize seizure outcome.
In patients with short-term epilepsy prior to surgery, seizure outcome was excellent in our study group (100% seizure free), even though the resection was restrictive in 73% of the patients. With more longstanding epilepsy, the rate of seizure freedom after surgery decreased to 64%. From this it follows that the duration of epilepsy is the strongest predictor for seizure outcome. Our data show that this holds true even for the long-term follow-up without any running-down phenomenon, irrespective of the duration of epilepsy prior to surgery.
Hugelshofer et al. reported on 41 patients with epilepsy; sufficient follow-up was available in 36 patients.
13
Engel Class I was achieved in 72% of the cases using lesionectomy including the rim as the operative technique. The study by Hugelshofer et al. reported on a relatively large patient cohort and, for the first time, provided data for 12 pediatric patients suffering from medically refractory epilepsy. The authors did not provide separate seizure outcome rates for this particular group. Nonetheless, they stated that there is a significant correlation between the duration of preoperative seizures and the postoperative Engel score, which was not shown in detail. This aspect could also be verified in the present study.
Both our study and that of Hugelshofer et al. 13 argue for an early intervention in pediatric patients with CCMassociated epilepsy and the performance of rather early surgery. With longer symptom duration, outcomes become worse, even with a more extensive surgical approach.
Surgery for CCMs in the pediatric population is safe. In our series the rate of a mild postoperative deficit was 4.5%. There was a relevant rate of permanent anticipated deficits (9%), as discussed and balanced with the benefit of treatment with the patients and caregivers prior to surgery. Furthermore, the impairing effect of antiepileptic drug treatment on children's cognition is frequently stated. 19 Seizure reduction as well as discontinuation of AED therapy were both shown to have significant effects on improving cognition and other neuropsychological abilities. 9, 11 In the presented series, 59.1% of all patients were successfully weaned from AEDs. Overall, interdisciplinary counseling of pediatric patients with CCM-associated epilepsy should lead to early epilepsy surgery.
Conclusions
Cerebral cavernous malformations are benign and usually not life-threatening lesions but are often complicated due to seizures and epilepsy. Counseling parents and caregivers of sick children can be a very challenging task. This is of particular importance in planning elective procedures such as the resection of a CCM. In the absence of prospective or even randomized studies, a differentiated workup in a retrospective manner is the best information currently available. We are well aware that our data are based on a small patient group.
Seizure outcome is favorable after surgical treatment of a CCM. An interdisciplinary approach led to a favorable seizure situation. Our data support the hypothesis that seizure outcome is worse with longer seizure duration prior to surgery, and thus early intervention is recommended. Even in cases of multiple CCMs and epilepsy, surgery should be considered. 
